Skip to main content
. 2019 May 31;19:486. doi: 10.1186/s12879-019-4136-7

Table 3.

Antibiotic susceptibility profiles of vancomycin resistant E. casseliflavus/gallinarum

Isolate # AMP GEN ERY TET MXF NIT DAPa LIZ TEC VAN vanA vanB
EM0085 S S R R S S N S S R
EM0176 S S R S S I N S S R +
EM3113 S S R R S S N S S R
EM0476 S S S S I S N S R R +
EM2016 S S R R S S S S S R +
EM0040 S S S S R S N S S R
EM0049 S S S S R S N S S R +
EM0149 S S S S I S S S S R
EM0477 S S S S I S S I R R +
EM1161 S S S S S S S S S R +
EM0162 S S I S R S N R R R +
EM0074 S S S S I S S S S R
EM0014 S S S S S S S S S R
EM0116 S S S S S S S S S R +
EM0022 S S S S S S S S S R
EM0056 S S S S S S S S S R
EM0099 S S S S S S N S S R
EM0010 S S S S S S S S S R +
EM0018 S S S S S S S S S R
EM1009 S S S S S S S S S R
Total R/+ (%) 0 0 04 (20) 03 (15) 03 (15) 0 0 01 (5) 03 (15) 20 (100) 06 (30) 03 (15)

E. casseliflavus & Enterococcus gallinarum are intrinsically resistant to vancomycin

AMP ampicillin, VAN vancomycin; aGEN high level gentamicin, ERY erythromycin, TET tetracyclin, MXF moxifloxacin, NIT nitrofurantoin, DAP daptomycin, TEC teicoplanin, LIZ linezolid, S Susceptible, I Intermediate, R Resistant, N non-susceptible; −, Negative; +, Positive